SCHEMBL7082086

SCHEMBL7082086

CC(=O)c1ccc(CCc2ccccc2)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.58
ALDH1A1 P00352 3/20 0.58
PRNP P04156 1/20 0.58
RECQL P46063 1/20 0.58
RXFP1 Q9HBX9 1/20 0.58
HPGD P15428 2/20 0.50
DAO P14920 2/20 0.45
HDAC6 Q9UBN7 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
GSK3B P49841 1/20 0.43
FFAR1 O14842 1/20 0.43
KMT2A Q03164 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
USP2 O75604 1/20 0.42
CCNE1 P24864 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077550 0.84 LMNA (0.51) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL17996050 0.82 FAAH (0.49) LMNAALDH1A1HPGDDAONPC1
SCHEMBL4058053 0.78 ALDH1A1 (0.60) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL3199622 0.78 ALDH1A1 (0.60) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL7828353 0.78 ERCC5 (0.57) RECQLDAOHDAC6HDAC3HDAC4
SCHEMBL10639931 0.77 ALDH1A1 (0.63) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL13838138 0.76 LMNA (0.88) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL3186013 0.75 ALDH1A1 (0.66) LMNAALDH1A1PRNPRECQLRXFP1
SCHEMBL25283341 0.75 ALDH1A1 (0.56) LMNAALDH1A1PRNPRECQLRXFP1
Acetone SCHEMBL3486840 0.74 ALDH1A1 (0.70) LMNAALDH1A1RXFP1HPGDHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP disclosed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP disclosed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 LMNA 3637/4885ALDH1A1 145/4885PRNP 1621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.